Discovery, Innovation and Commercialization

Workshop Series & Certificate Program

Workshops will be held on Fridays, 1:00- 4:00 p.m., June 25, July 30, August 20, October 8 and October 29, 2010. Topic, agenda and location details for each workshop are below:

Workshop 1: Discovery, Innovation and the Business of Medicine Friday, June 25, 20101 - 4 p.m. The Ohio State University Davis Heart and Lung Research Institute,Room 170, 473 W. 12th Ave., Columbus

1:00 - 1:10 Welcome Chandan Sen, PhD Associate Dean for Research, Professor of Surgery, College of Medicine, Director of Pilot Studies Program-CCTS, and Executive Director of t the Comprehensive Wound Center, The Ohio State University.

Karen Wruck, PhD Associate Dean for Graduate Programs, Dean’s Distinguished Professor and Professor of Finance, Fisher College of Business, The Ohio State University

Rebecca Jackson, MD Associate Dean for Clinical Research, Professor of Endocrinology, Diabetes, Metabolism, Physical Medicine, College of Medicine, and Director of CCTS, The Ohio State University

1:10 - 1:30 Steven Gabbe, MD Senior Vice President for Health Sciences, The Ohio State University, and Chief Executive Officer, The Ohio State University Medical Center

1:30 - 1:50 Christine Poon Dean and John W. Berry, Sr. Chair in Business, Fisher College of Business, The Ohio State University

1:50 - 2:05 Q&A for Steven Gabbe and Christine Poon

2:05 - 2:20 Break for refreshments

2:20 - 2:40 Michael Bills Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University

2:40 - 3:00 Jane New Associate Director, Technology Licensing & Commercialization, The Ohio State University

3:00 - 3:10 Q&A for Michael Bills and Jane New

3:10 - 3:20 Setup and framing of breakout/discussion sessions Michael Bills

3:20 - 3:40 Breakout sessions

3:40 - 3:50 Introduction of upcoming speakers Chandan Sen, Karen Wruck, Michael Bills

3:50 - 4:00 Closing remarks Chandan Sen, Karen Wruck

Discovery, Innovation and Commercialization Workshop Series & Certificate Program

The Ohio State University Center for Clinical and Translational Science (CCTS),in collaboration with Ohio State’s Fisher College of Business and College of Medicine,is pleased to announce the “Discovery, Innovation and Commercialization WorkshopSeries,” which will focus on commercializing innovations in health care and medicine.

The goal of the five-workshop series is to provide CCTS pilot study awardees, K scholars and other interested clinical and translational investigators with information and support that will help them translate their scientific discoveries into commercially viable products and services that improve patient outcomes.

CCTS pilot-funded investigators who attend at least four of the five workshops will receive a certificate in “Discovery, Innovation, and New Product and Service Development”and will be eligible to be selected for consultative support from the Fisher College ofBusiness to help commercialize their discoveries.

The application for consultative services is available athttps://osu.qualtrics.com/SE/?SID=SV_4IvX1oHc9Hx8CHi.

Otherwise, you may also visit www.cctsworkshops.eventbrite.com for a link to theapplication and to register for and learn about workshops in this series.

Follow us on Twitter, share your feedback, and help us spread the word about thisexciting workshop series! http://twitter.com/cctsworkshops

Workshop 2: Commercialization and Incubation of Intellectual Property in Health Care and Medical Businesses Friday, July 30, 20101 - 4 p.m. The Ohio State University Biomedical Research Tower, Room 115, 460 W. 12th Ave., Columbus

1:00 - 1:10 Welcome

1:10 - 2:40 Presentations Michael Camp, PhD Academic Director, Center for Entrepreneurship, Fisher College of Business, The Ohio State University

Susan Rector Partner, Intellectual Property and Technology Practice, Schottenstein Zox & Dunn, Columbus, Ohio

Earl LeVere Partner, Intellectual Property and Technology Practice, Schottenstein Zox & Dunn, Columbus, Ohio

Orlando “Lon” Simonetti, PhD Research Director, Cardiovascular MRI and CT, and Associate Professor of Internal Medicine and Radiology, College of Medicine, The Ohio State University

2:40 - 2:55 Q&A

2:55 - 3:10 Break for refreshments

3:10 - 3:45 Breakout sessions

3:45 - 4:00 Closing remarks

Workshop 3Innovation Practice and Process: A Patient & Caregiver-Centric ApproachFriday, August 20, 20101 - 4 p.m. The Ohio State University Biomedical Research Tower, Room 115, 460 W. 12th Ave., Columbus

1:00 - 1:10 Welcome Chip Souba, MD Dean, College of Medicine, The Ohio State University

1:10 - 2:40 Presentations Clay Marsh, MD Senior Associate Vice President for Health Sciences Research; Vice Dean for Research and Professor of Internal Medicine, College of Medicine; Executive Director of the Center for Personalized Health; Director of the Center for Critical Care and Respiratory Medicine, The Ohio State University

Michael Bills Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University

2:40 - 2:55 Q&A

2:55 - 3:10 Break for refreshments

3:10 - 3:45 Breakout sessions

3:45 - 4:00 Closing remarks

Workshop 4Allocating Research Resources: Evaluating, Attracting, and Researching FundingFriday, October 8, 20101 - 4 p.m. The Ohio State University Davis Heart and Lung Research Institute, Room 170, 473 W. 12th Ave., Columbus

1:00 - 1:10 Welcome Michael Bills Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University

1:10 - 2:40 Presentations Michael Leiblein, PhD Associate Professor of Strategic Management, Fisher College of Business, The Ohio State University

Sampath Parthasarathy, PhD Holder of the Klassen Chair in Cardiothoracic Surgery, Professor of Surgery, College of Medicine, The Ohio State University; founder of InVasc Therapeutics

2:40 - 2:55 Q&A

2:55 - 3:10 Break for refreshments

3:10 - 3:45 Breakout sessions

3:45 - 4:00 Closing remarks Michael Bills

Workshop 5The Crucial Role of Intangibles in the Health Care Innovation Value Chain Friday, October 29, 20101 - 4 p.m. The Ohio State University Davis Heart and Lung Research Institute, Room 170, 473 W. 12th Ave., Columbus

1:00 - 1:10 Welcome Michael Bills Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University

1:10 - 2:40 Presentations Anthony Rucci Clinical Professor of Management and Associate to the Dean for Executive Education, Fisher College of Business, The Ohio State University

Vincent Pompili, MD, FACC Director of Interventional Cardiovascular Medicine, Director of Cell-Based Therapies, The Ohio State University Medical Center, Professor of Internal Medicine, College of Medicine, The Ohio State University

2:40 - 2:55 Q&A

2:55 - 3:10 Break for refreshments

3:10 - 3:45 Breakout sessions

3:45 - 4:00 Closing remarks Michael Bills

Michael Bills

With more than two decades of experience in new product and brand innovation, Michael Bills is an internationally recognized expert on consumer- centricity and the creation of integrated, multi-channel experiences for companies as diverse as GE, Calvin Klein, Microsoft, Coca-Cola and Apple. As Executive in Residence at The Ohio State University Fisher College of Business, Bills teaches graduate level courses in innovation and brand marketing and has developed numerous platform elements for the Fisher Innovation Initiative. Prior to joining the Fisher College he was Managing Partner, the Americas, for international consulting firm, Fitch (a division of WPP) and was President of Retail Planning Associates. Bill’s work has taken him around the world, with engagements in 17 countries; in addition, he has shared his perspectives on CNBC, CNN and Sky Radio, as well as being quoted in leading publications including Time, BusinessWeek and Fortune Magazine.

The Speakers entrepreneurship, Professor Camp has directed or led several national and global programmatic research initiatives. He teaches graduate and undergraduate courses in the entrepreneurship program. His consulting work focuses on technology commercialization, new venture creation, the strategic and financial performance of high-growth ventures, and the regional economic impact of the innovation-entrepreneurship nexus. Dr. Camp holds dual degrees from two institutions, including aPhD in business strategy and a master’s degree in organization theory from The Ohio State University, and an MBA and BS in business administration from West Virginia University.

Steven G. Gabbe, MD

Dr. Steven Gabbe is the Senior Vice President for Health Sciences for The Ohio State University and Chief Executive Officer of The Ohio State University Medical Center. Since returning to Ohio State in this new role in 2008, Dr. Gabbe has led the Medical Center to its first ranking on the U.S. News & World Report “Best Hospitals” Honor Roll of the nation’s top 21 hospitals; to recertification as a Magnet Hospital for nursing excellence; to honors as a Best Place to Work in central Ohio for the third consecutive year; to growth in biomedical research funding to more than $205 million per year; and to University Board of Trustees approval of ProjectONE, the largest construction project in University history. The $1-billion ProjectONE will be completed in 2014 and include a new cancer hospital, critical care tower, outpatient center, research laboratories and classrooms – all designed to advance the Medical Center’s mission to improve people’s lives through innovation in patient care, education and research. A native of New Jersey, Dr. Gabbe earned his undergraduate degree magna cum laude from Princeton University and his medical degree with Alpha Omega Alpha honors from Cornell University Medical College. He was a medical intern at New York Hospital, a research fellow in reproductive medicine at Boston Hospital for Women and a research fellow in biological chemistry at Harvard Medical School before completing his residency in obstetrics and gynecology at Boston Hospital for Women and a clinical fellowship in obstetrics and gynecology at Harvard Medical School. Dr. Gabbe served on the obstetrics and gynecology faculties of the University of Southern California, University of Colorado and University of Pennsylvania before joining The Ohio State University College of Medicine in 1987 as Professor and Chair of Obstetrics and Gynecology. He was named Chair of Obstetrics and Gynecology at the University of Washington Medical Center in 1996 and Dean of the Vanderbilt University School of Medicine in 2001. During Dr. Gabbe’s tenure at Vanderbilt, National Institutes of Health research funding increased by 77 percent and the number of faculty grew by 66percent, to more than 1,800. He was recruited to Ohio State as Senior Vice President for Health Sciences and CEO of its Medical Center in 2008. Dr. Gabbe is one of the world’s leading experts on the complications of diabetes and pregnancy. He is the author of more than 170 peer-reviewed papers and senior editor of the leading textbook in his field, Obstetrics: Normal and Problem Pregnancies. Dr. Gabbe has held leadership positions with the Association of American Medical Colleges (AAMC) and National Institutes of Health (NIH). He also served as Co-Chair of the Liaison Committee for Medical Education, the accreditation body for North American medical schools. Dr. Gabbe is a member of the Institute of Medicine and, in 2009 was appointed chair of the AAMC MR5 MCAT Review Committee. Dr. Gabbe and his wife, Dr. Patricia Temple Gabbe, have four children: Adam, Erica, Amanda, and Daniel; and two grandchildren: Alexander and Marin.

S. Michael Camp, PhD

Dr. S. Michael Camp serves as the academic director for the Center for Entrepreneurship in the Fisher College of Business at The Ohio State University. He is also founder and CEO of the Kairos IP Institute, a global expert network and proprietary research organization for rapid screening and commercialization of early-stage technology with emphasis on monetizing IP for the world’s leading R&D institutions. As academic director at Fisher, Dr. Camp sets the strategic direction and programmatic platform for Ohio State’s entrepreneurship education program. He oversees the design and development of the academic and outreach programs and directs strategic partnerships with other entrepreneurship and technology commercialization support organizations. Dr. Camp was recently recognized by CNN Money and Fortune Small Business as one of the top entrepreneurship professors in the country. In 2009, he received the coveted Olympus Innovation Award for teaching pedagogy in technology and innovation management. In addition to teaching the traditional graduate and undergraduate curricular offerings, Dr. Camp is the architect and developer of the new and growing Undergraduate Interdisciplinary Minor in Entrepreneurship and the Technology Entrepreneurship and Commercialization (TEC) Academy at The Ohio State University. TEC is a proposed interdisciplinary, graduate-level specialization training in the strategies and techniques for evaluating the commercial potential of new technologies. TEC teams work with local technology or entrepreneurial experts to develop commercialization strategies for live technologies provided by technology hosts (e.g., Battelle Memorial Institute, OhioHealth, Ohio University, The Ohio State University and The Research Instituteat Nationwide Children’s Hospital). Dr. Camp’s research interests focus on the creation and performance of new ventures and the regional economic impact of innovation and entrepreneurship. He has published articles in leading journals including Strategic Management Journal, Academy of Management Executive, and EntrepreneurshipTheory & Practice. Throughout his research career, including five years as vice president of research for the Ewing Marion Kauffman Foundation, the world’s leading foundation in the advancement of

Rebecca D. Jackson, MD

Dr. Jackson is Director of The Ohio State University Center for Clinical and Translational Science, the academic home of the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA). She participated in formalized programs of clinical and translational research training as a junior faculty member, first through the National Center for Research Resources (NCRR)-sponsored Clinical Associate Physician Award and later through a Physician Scientist Award to develop expertise in molecular biology and basic science discovery. She has been a faculty member at The Ohio State University College of Medicine since 1983, and in August 2006, having accepted the position as PI and Director of the Center for Clinical and Translational Science (CCTS), she was promoted to Associate Dean for Clinical Research in Ohio State’s College of Medicine, reporting directly to the Senior Vice President for Health Sciences. Dr. Jackson is a well-recognized clinical and translational investigator in metabolic bone disease and women’s health. She has had continuous funding for the past 20 years and has been PI of two large longitudinal studies: the NHLBI-sponsored Women’s Health Initiative and the NIAMS-sponsored Osteoarthritis Initiative. Currently, Dr. Jackson is PI on NIH U01(1) and NIH N01(1) and co-investigator on NIH R01(3) and in January 2007 received funding as PI of a genome-wide association study of the genetic determinants of hip fracture. She was the founding director of Ohio State’s CCC Clinical Trials Office (CTO). Under her leadership at CCC-CTO, the clinical and translational research effort at The Ohio State University Comprehensive Cancer Center –Arthur G. James Cancer Hospital and Richard J. Solove Research Institute was transformed to a novel, integrated and robust shared service. The fact that this fundamental change in the conduct of clinical research at Ohio State’s Comprehensive Cancer Center-James Cancer Hospital (OSUCCC-James) took place over less than 14 months and culminated in funding by the National Cancer Institute demonstrates Dr. Jackson’s energy and commitment to working with individuals to create consensus and develop systems that are responsive to investigators. As the PI of the CTSA and Director of the CCTS, Ohio State has invested Dr. Jackson with the authority to lead the University’s development of clinical and translation research. She has ultimate responsibility for programmatic functions, operations and strategic planning for Ohio State’s CCTS. Dr. Jackson is the primary contact to facilitate and maximize collaboration and interaction between the CCTS, the NIH (NCRR) and national CTSA consortium, as well as both internal and external groups and individuals. She represents the CCTS and its mission to support clinical and translation science at the University’s highest leadership levels; chairs the CCTS Management Committee to integrate the needs of the CCTS with The Ohio State University Medical Center and OSUCCC-James; and chairs the CCTS Executive Committee. Dr. Jackson is responsible for the management of CCTS functions and has direct responsibility for performance of co-PIs and key program leaders with the advice of the Executive Committee. She works with the CCTS Administrative Director to maximize the value of resources and programs across the Ohio State member Colleges by identifying priorities and new directions. Dr. Jackson oversees the formal ongoing evaluation and process improvement program and negotiates priorities among key programs. She is responsible for ensuring the adoption of best practices in all CCTS research support programs.

Michael Leiblein, PhD

Michael Leiblein, PhD, is an Associate Professor in the Strategic Management group of The Ohio State University Fisher College of Business. Professor Leiblein’s research examines the relationship between firm organization and performance in technology-intensive industries. His recent work examines relationships between aspects of technical problems (e.g., problem complexity and structure, exchange specificity and uncertainty), organization (e.g., outsourcing and various alliance structures) and performance (e.g., static and dynamic changes in technical and financial performance). His research has received a number of academic awards and been disseminated into practice through outlets such as the Financial Times of London. Professor Leiblein has led courses and seminars on business, corporate, and technology strategy in a variety of undergraduate, master’s, doctoral, and executive programs and has consulted on issues relating to business, corporate, and technology strategy in the U.S. and Europe for a wide range of firms and industry groups. In his free time, he enjoys hiking and sightseeing throughout the American Southwest.

Earl LeVere

Earl LeVere is a Partner in Schottenstein Zox & Dunn ’s Intellectual Property and Technology Practice Area and its Commercial Litigation Practice Group, where he focuses on intellectual property and information technology issues related to patent, copyright, trademark, life sciences, computer, internet, ecommerce disputes and entertainment law. Throughout his practice, Mr. LeVere has represented clients in intellectual property litigation matters across the country; helped clients establish internal procedures to protect proprietaryinformation; drafted intellectual property license and assignment agreements and agreements for the joint development and use of intellectual property.

Sampath Parthasarathy, PhD, MBA, FAHA

Sampath Parthasarathy, PhD, MBA, FAHA is a biomedical scientist with a research focus on lipids, lipoproteins, oxidative stress and the biology of endothelial cells and macrophages and an emphasis on chronic diseases, including atherosclerosis, diabetes and heart failure. His primary appointment is as holder of the Klassen Chair and Professor of Surgery, with secondary appointments as professor of Internal Medicine and as Professor of Human Nutrition. He directs research in the division of cardiothoracic surgery. Dr. Parthasarathy obtained his PhD in Biochemistry from the Indian Institute of Science and served as a postdoctoral fellow in several institutions. He was a faculty member at the University of California, San Diego, Emory University, and the Louisiana State University Medical School before joining The Ohio State University Medical Center. Dr. Parthasarathy, who has been credited with the co-discovery of oxidized low density lipoprotein, has published over 225 full-length research articles and authored a book, Modified Lipoproteins in the Patho-genesis of Atherosclerosis. He serves on the editorial boards of several journals and on numerous national and international committees. Dr. Parthasarathy organized several national and international conferences and has won numerous awards, including a Special Recognition Award from the American Heart Associa-tion, the Ranbaxy award, and Van Deenen Memorial Lecture. In addition, he has trained more than one hundred graduate students and postdoctoral fellows and was recently named as the Mentor of the Year by The Ohio State University Davis Heart and Lung Research Institute. Finally, Dr. Parthasarathy has been continuously funded by the National Institutes of Health for more than 25 years. One of the founders of InVasc Therapeutics, Inc., an Atlanta/Columbus based-pharmaceutical company interested in cardiovascular drug development, he is internationally recognized for his work in the area of atherosclerosis. Dr. Parthasarathy has been extensively involved in drug discovery and served as a consultant for numerous major pharmaceutical companies, including Bristol Myers Squibb, Johnson & Johnson, Atherogenics, and Vyrex Pharmaceuticals. Dr. Parthasarathy synthesized and patented water-soluble probucol at the University of California in San Diego. It was this compound that later formed the basis for AGI-1067, the lead product for Atherogenics which raised nearly $700 million to advance it. Dr. Parthasarathy holds several patent rights and has designed many of the key agents under investigation at InVasc Therapeutics.

Clay Marsh, MD

Dr. Marsh is Senior Associate Vice President for Health Sciences Research, Vice Dean for Research for The Ohio State University College of Medicine, Executive Director of Ohio State’s Center for Personalized Health, and the Director of the Center for Critical Care and Respiratory Medicine. He is also Professor of Internal Medicine and former director of the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine. Dr. Marsh received his undergraduate (Biology) and medical degrees at West Virginia University and did his Internal Medicine residency and Pulmonary and Critical Care fellowship at The Ohio State University in Internal Medicine. He began his academic career in the Division of Pulmonary Medicine as a clinical instructor in 1993 and in 2003 became the director of the division. Dr. Marsh then ascended to directorship of the Center for Critical Care and Respiratory Medicine, one of Ohio State’s Medical Center signature programs that oversees institutional clinical, educational and research programming in critical care, respiratory disease, trauma, wound, burn, sleep and allergy-based care. In 2009, he took his present position as Vice Dean for Research in the College of Medicine and as Senior Associate Vice President for Research in the Office of Health Sciences. Dr. Marsh is an NIH-funded investigator and his laboratory focuses on translational research in the area of macrophage biology, with an emphasis on pulmonary fibrosis and tissue microenvironment/angiogenesis and applied genomics related to these areas. Also interested in understanding the molecular mechanisms underlying human health and wellness, Dr. Marsh leads the efforts in Personalized Health Care at The Ohio State University, where he and the University’s senior leadership are directing the effort in transforming healthcare delivery by creating pilot programs in wellness and chronic disease, testing solutions that produce lower cost and higher quality outcomes. Under his direction, Ohio State is a partner in the Coriell Institute’s Personalized Medicine Collaborative. Dr. Marsh is leading Ohio State’s efforts in partnering with the Institute for Systems Biology to create the P4 Medicine Institute. Listed in America’s Best Doctors©, he has a rich history of mentoring MD, MD/PhD and PhD students, post-doctoral researchers and junior faculty. Dr. Marsh is the former director of the scientific board and the immediate past chair of the Board of Directors of the Stanley Sarnoff Foundation for Cardiovascular Medicine, and is on the National Advisory Board for the Pulmonary Bioinitiative for Lung Health and Disease with Battelle Memorial Institute and the Institute for Systems Biology.

Jane New

Jane New joined The Ohio State University Office for Technology Licensing in 2001 and is primarily responsible for the licensing and commercialization of the University’s life sciences portfolio. In her current role as associate director, she continues to work with Ohio State’s Colleges of Medicine, Pharmacy, Biological Sciences, Veterinary Medicine and Food, Agriculture & Environmental Science. Prior to joining Ohio State, New was President of the Kansas Innovation Corporation, where she focused on technology transfer and technology-based new business development in Northeast Kansas and managed a pre-seed fund and its portfolio of investments. She has also consulted for the National Institutes of Standards and Technology in its Advance Technology Program. New holds both an MBA and a Master’s Degree in Accounting and Information Systems from the University of Kansas.

Christine A. Poon

Christine A. Poon was appointed Dean and John W. Berry, Sr. Chair in Business at The Max M. Fisher College of Business at The Ohio State University in April 2009. Poon comes to Fisher after a 30-year career in the healthcare industry, most recently as vice chairman and worldwide chairman of Pharmaceuticals at Johnson & Johnson. She served as a member of the company’s Board of Directors and Executive Committee and was responsible for managing the pharmaceutical businesses of the company. Her areas of expertise include domestic and international business operations and sales and marketing. Poon began her career at Johnson & Johnson in 2000 as company group chairman of Pharmaceuti-cals and was appointed worldwide chairman of Pharmaceuticals in 2001. She was appointed worldwide chairman of Medicines & Nutritionals in 2003 and was named a vice chairman of the Board of Directors in 2005. In 2007, Poon assumed responsibility for the Johnson & Johnson Development Corporation, the Corporate Office of Science and Technology, the Corporate Office of Information Management, Worldwide Procurement and Worldwide Operations. Prior to joining Johnson & Johnson, Poon spent 15 years at Bristol-Myers Squibb, where her most recent position was president of International Medicines. Her career at Bristol-Myers Squibb comprised marketing and strategic planning positions, including stints as president of Medical Devices and senior vice president for Canada and Latin America Pharmaceutical Operations.

Vincent J. Pompili, MD, FACC

Vincent J. Pompili, MD, FACC is Director of Interventional Cardiovascular Medicine and Director of Cell-Based Therapies at The Ohio State University Medical Center in Columbus, Ohio. He is also a Professor of Internal Medicine at The Ohio State University College of Medicine. After graduating from The Case Western Reserve University School of Medicine, Dr. Pompili completed his residency at Johns Hopkins University, followed by a fellowship in Cardiology at The University of Michigan and a fellowship in Interventional Cardiology at The Mayo Clinic. Dr. Pompili’s primary clinical focus is interventional cardiology and acute coronary syndromes, and his research interest is cardiovascular regenerative medicine. He served as the national principal investigator on the third FDA approved clinical trial in stem cell therapeutics in the United States and holds expertise in the pre-clinical and clinical trial design of these types of studies. He also has been a principal investigator in numerous National Institutes of Health (NIH) sponsored clinical trials. Dr. Pompili has published numerous journal articles in such publications as Circulation, American Journal of Medicine, Cell Transplantation, Angiology, Journal of the American College of Cardiology and Cardiovascular Research. In addition to seeing patients at The Ohio State University Richard M. Ross Heart Hospital, Dr. Pompili also supports Ohio State’s University Hospital East Heart Program

Poon is on the Board of Directors of Prudential Financial, Inc., in Newark, N.J., and the Supervisory Board of Royal Philips Electronics in Amsterdam. She was recently named to Boston University’s Board of Trustees. In 2004, she was named Woman of the Year by the Healthcare Businesswomen’s Association and in 2005 named Business Leader of the Future by CNBC/Wall Street Journa. Poon earned a BA in Biology from Northwestern University, an MA in Biology/Biochemistry from St. Louis University and an MBA in Finance from Boston University.

Susan Rector

Susan Rector, Partner, leads Schottenstein Zox & Dunn’s Intellectual Property Practice Group, which oversees the professional quality of service delivered to clients in intellectual property law. She has advised publicly and privately held companies in all aspects of intellectual property ownership and has assisted start-up and established businesses in conducting business online or commercializing technology. Rector has extensive experience with software acquisition and licensing, technology-basedcompanies and the legal issues encountered in conducting business online. She has prosecuted more than 450 applications with the U.S. Patent and Trademark Office and numerous applications with the U.S. Copyright Office. Rector also has experience in a wide variety of business transactions, including business formation, restructurings and mergers and acquisitions. She has advised institutional investors in making investments in venture capital funds or other equity investments and has assisted companies in raising debt and equity through the private sale of securities. Rector also provides ongoing advice and counsel to family- and privately-held businesses. Complementing her practice, she serves as partner in charge of marketing and business development. In this role, she oversees the firm’s marketing strategies and brand development to successfully position Schottenstein Zox & Dunn within the legal industry. Rector also serves as the editor of Currents, the firm’s newsletter, which features issues and trends in intellectual property and e-commerce law.

Anthony Rucci

Tony Rucci joined the faculty at the Fisher College of Business at Ohio State University in 2006 following a 25 year career as an executive officer with three Fortune 100 companies: Baxter International, where he was Senior Vice President of Corporate Strategy and Business Development; Sears Roebuck and Co., where he was Executive Vice President and Chief Administrative Officer; and Cardinal Health, where he was President of Strategic Corporate Resources and Chief Administrative Officer. He has held a broad range of senior officer responsibilities, including extensive board of directors and governance experience, merger and acquisition responsibilities, large scale organizational transformation efforts, as well as international responsibilities. His roles have included global responsibility for corporate strategy and business development, legal, human resources, investor relations, information technology, quality and regulatory affairs, media relations and communications, government affairs, corporate branding, procurement and sourcing, ethics, security, real estate, aviation

. . . . continues on next page

Orlando “Lon” Simonetti, PhD

After receiving his BS in zoology with a minor in electrical engineering and MS degree in biomedical engineering from The Ohio State University, Dr. Simonetti began his career in MRI research in 1989 as a graduate student in biomedical engineering at Case Western Reserve University, where he earned his doctorate. In 1992, he joined the Siemens MRI Research and Development group, and by 1997 was promoted to Director of Cardiovascular MR R&D at Siemens. During his 13-year career at Siemens, Dr. Simonetti patented nine cardiovascular MRI techniques and was responsible for developing many of the methods that have become mainstays of cardiovascular MRI. He has more than 75 peer-reviewed articles, and his article on delayed enhancement imaging is the most widely cited article of the past 25 years in the journal Radiology. In 2005, Dr. Simonetti accepted a position at The Ohio State University as director of cardiovascular MRI and CT research at the OSU Ross Heart Hospital. He currently serves on the board of trustees of the Society for Cardiovascular Magnetic Resonance and the editorial board for the Journal of Cardiovas-cular Magnetic Resonance. This year, Dr. Simonetti was named a Fellow of the International Society for Magnetic Resonance in Medicine, where he chairs the Student Stipend Committee and serves on several other committees. In 2008, together with two other Ohio State University faculty members and one Ohio State graduate student, he founded EXCMR, Ltd to commercialize technology that enables a new method of cardiovascular stress testing. The company took second place in the 2008 Fisher Student Business Plan Competition in Ohio State’s Fisher College of Business, and was named Central Ohio Startup of the Year in 2009. EXCMR has received grant funding from TechColumbus, The Global Cardiovascular Innovations Center and the National Institutes of Health. The company has used this funding for market research, to perform clinical feasibility studies at Ohio State and to design a production prototype. EXCMR hopes to enter the market with their device next year.

Chandan Sen, PhD

Chandan Sen, PhD, is a tenured Professor of Surgery and Associate Dean for Research in The Ohio State University College of Medicine. He is also Executive Director of the Ohio State University Comprehensive Wound Center. Dr. Sen directs the Medical Center’s Technology Commercialization and Industry Partnership program. He also serves on the National Institutes of Health (NIH) panel on public-private partnerships. Dr. Sen has been appointed Champion of Change (CoC) for Ohio State on the NIH national CoC program. He directs two programs in The Ohio State University’s CTSA (NIH Clinical and Translational Science Award) program - the Center for Clinical and Translational Science (CCTS: the Novel Technologies/Methodologies program and the Pilot Studies program). Dr. Sen has been appointed by College Dean Wiley Souba, MD, to develop strategic partnerships between the College of Medicine and The Ohio State University Fisher College of Business. For the last 10 years he has been editor-in-chief of the #1 rated journal in oxygen & redox biology, Antioxidants & Redox Signaling, which has an impact factor 6.19. Dr. Sen is also an associate editor of the prestigious American Physiological Society journal, Physiology Genomics. He is editor-in-chief of the Wound Healing Society’s yearbook Advances in Wound Care. Dr. Sen has published more than 250 publications and is cited more than 700 times yearly in the literature of his field. He is a permanent member of the NIH Surgery, Anesthesia and Trauma study section.

and crisis management. He has also been Chairman of the Board of Sears Mexico, and held a joint role as CEO of the Ohio State University Physicians, Inc. and Senior Associate Vice President for Health Sciences at the Ohio State University Medical Center. Academically, Rucci has been Dean of the College of Business at the University of Illinois, Chicago and a tenured professor. He has published over twenty five articles and book chapters, including the Harvard Business Review and Fortune magazine. He has been on the editorial board of several professional journals, as well as an ad hoc reviewer for book publishers, including Harvard Business School Press. He has taught at several universities, including Ohio State University, Bowling Green State University, the University of Illinois, Chicago, and the University of Texas, Dallas. He is a frequently sought speaker, and has delivered over 125 invited speeches and keynote addresses over the past ten years at major conferences and events. Rucci holds bachelors, masters and PhD degrees in Industrial and Organizational Psychology from Bowling Green State University. His current teaching, publication and consulting activities focus on the areas of strategy development and execution, leadership effectiveness, team effectiveness, and the role of intangibles in the value creation chain. Most recently, he has received the 2010 Pacesetter Award from the Fisher College for Best Graduate Faculty, the 2008 Distinguished Career Executive Award by the Academy of Management, as well as the Outstanding Professor Award from the 2009 MBA class and the 2008 Executive MBA class at Ohio State University. (8.09)

. . . . continued from previous page

Chip Souba, MD, ScD, MBA

Wiley W. “Chip” Souba (pronounced SHOW-buh) serves as Dean of the College of Medicine and Vice President and Executive Dean for Health Sciences at The Ohio State University. He holds a faculty appointment as professor in the Department of Surgery and in Physiology and Cell Biology. Before coming to Ohio State in 2006, Dr. Souba served as Chairman of the Department of Surgery at Penn State College of Medicine, Surgeon-in-Chief at Penn State’s Hershey Medical Center and Director of the Penn State Hershey Center for Leadership Development. Prior to assuming his position at Penn State, he served as Chief of Surgical Oncology at the Massachusetts General Hospital and Professor of Surgery at Harvard Medical School from 1993 to 1999. He began his career as a faculty member at the University of Florida in 1987. Dr. Souba is an Alpha Omega Alpha (AOA) graduate of the University of Texas Medical School in Houston, where he subsequently did his general surgery training. During his surgical residency, Dr. Souba completed a fellowship in surgical research at the Brigham and Women’s Hospital and earned a Doctorate in Science in Nutritional Biochemistry at the Harvard School of Public Health.

. . . . continues on next page

Karen Hopper Wruck, PHD

Karen Wruck, PhD, is Associate Dean for Graduate Programs, Dean’s Distinguished Professor and Professor of Finance at The Ohio State University Fisher College of Business. She conducts research and teaches in the fields of financial and organizational economics, specializing in corporate finance, restructuring, financial distress, corporate governance and management compensation. Dr. Wruck has published numerous articles in leading academic journals and developed highly successful courses for delivery to MBAs and executives. In addition, her work and opinions have been highlighted in business periodicals. Dr. Wruck is associate editor of the Journal of Financial Economics, Journal of Corporate Finance, Journal of Financial Research and European Financial Management and serves as ad hoc referee for many other academic journals. She has been selected as the outstanding faculty member by students in the core of the full-time MBA program and the executive MBA program at Ohio State, and has received a faculty-selected award for exceptional contributions toward graduate student intellectual and cultural growth at the University. Dr. Wruck serves as an academic director of the Financial Management Association and the Turnaround Management Association. A consultant to major corporations, she has worked on a number of high profile corporate litigation projects as an expert witness. Dr. Wruck holds an AB from Davidson College in Economics, and both an MS in Applied Economics and a PhD in Finance and Accounting from the University of Rochester. Prior to her appointment at Ohio State’s Fisher College of Business, Dr. Wruck was an associate professor at the Harvard Business School.

The project described was supported by Award Number UL1RR025755 from the National Center For Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

. . . . continued from previous page

In addition, he did a senior fellowship in Surgical Oncology at the MD Anderson Hospital and Tumor Institute in Houston, Texas. Dr. Souba has been ranked as one of The Best Doctors in America by his peers and has been recognized for his clinical expertise by Boston Magazine. He was funded by the NIH for 20 years to study the regulation of the altered amino acid metabolism that is characteristic of catabolic diseases and has published nearly 300 articles and 75 book chapters in this field. Dr. Souba has served as Editor of the Journal of Surgical Research since 1997 and was Editorial Chair of ACS Surgery from 2004-2009. Dr. Souba has long-standing interest in leadership development and has published more than 30 peer reviewed articles on topics such as adaptive challenges, change in academic medicine, professionalism, language and leadership, and leading oneself. He lectures globally on these topics.Dr. Souba and his wife have two children.